TepaneBTH'IecKHit apXHB, 2008, NfJ 7, C. 88-91

41. Komarova E. JI:, Afanasyeva E. A., Bulatova. M. M. et at.Downstream caspases are novel targets for the antiapoptoticactivity of the molecular chaperone hsp70. Cell&Stress Chap-erones 2004; 9: 265-275.

42. Steel R., Doherty J. P., Buzzard K. et al. Hsp72 inhibits apop-tosis upstream of the mitochondria and not through interac-tions with Apaf-l. J. BioI. Chem. 2004; 279: 51490-51499.

43. Fe"arini M., Heltai S., Zocchi M. R., Rugarli C. Unusual ex-pression and localization of heat-shock proteins in human tu-mor cells. Int. J. Cancer. 1992; 51: 613-619.

44. Hantschel M., PfISter K., Jordan A. et al. Hsp70 plasma mem-brane expression on primary tumor biopsy material and bonemarrow of leukemic patients. Cell Stress Chaperones 2000; 5:438-442.

37. ,Vabu/as R. M., Ahmad-Nejad P., Ghose S. et al. HSP70 as en-dogenous stimulus of the Toll/interleukin-1 receptor signalpathway. J. BioI. Chern. 2002; 277: 1510-1517.

38. Schmitt E., Parce//ier A., Gurbuxani S. et al. Chemosensitiza-tion by a non-apoptogenic heat shock protein 70-binding ap-optosis-inducing factor mutant. Cancer Res. 2003; 63: 8233-8240.

39. Li C. Y, Lee J. S., Ko Y. G. et al. Heat shock protein 70 in-hibits apoptosis downstream of cytochrome c release and up-stream of caspase-3 activation. J. Bioi. Chern. 2000; 275:25665-25671.

40. Buzzard K. A., Giaccia A. J., Ki//ender M., Anderson R. L. Heatshock protein 72 modulates pathways of stress-induced apop-tosis. J. Bioi. Chern. 1998; 273: 17147-17153. nOc-rynun3 14.02.08

C KOJIJIEKTHB ABTOPOB, 2008

Y~K 612.115(048.8)

M. A. lIanmeAee81, JI. H. KOmO8a2, A. A. TOKape8/, CPo H. AmaY/UlaxanO8/' 2

MEXAHH3MbI PEfYJUI~HH CBEPTbIB4HJJJI KPOBH

JIa6opaTOpHH tl>H3H'1eCKO~ 6HOXHMHH CHCTeMbI KpOBH rY [eMaTOJlOrHtleCKOrO Hay'lHOrO ueHTpa PAMH, MOCKBa

KJI JO q e B hI e C JI 0 B a: 0630P, C8epmb/8aHUe "PO8U, zeMocma3, mpoM6uH, zeMorjJllAUR

Key words: review, blood coagulation, hemostasis, thrombin, hemophilia

CBepTbIBaHHe KpOBH npe~CTaBJIHeT c060R CJIO)KHyIO CHCTeMYpeaK~HIt, 3anycKalOmHXCH npH nOBpe~eHHH cocy~a H Be~ymHx KJIOKaJIbHOMY nepexo~y nJIa3MbI KpOBH H3 }K~KOrO COCTOHHHH B re-JIe06pa3Hoe [1, 2]. CBepTbIBaHHe HBJlHerCH O~HHM H3 3BeHbeB CHC-TeMbI reMOCTaJa, KOTOpaH OTBe'laer 3a npe~OTBpameHHe KpOBono-TepH npH HapYlIIeHHH ~eJIOCTHOCTH COCY~HcTolt CHCTeMbI. B Ha-CTOHmee BpeMH CHCTeMa peaKUHR CBepTbIBaHHH H3yqeHa ~OBOJIbHOno~p06HO: 3a nOCJIe~HHe 15 JIeT - O'leHb 60JIbWoR CpOK JJ;JIH co-BpeMeHHolt 6HOXHMHH - B HeR He 6b1J1o OTKpbITO HH O~Horo HO-Boro 6eJIKa HJIH HOBOIt peaKUHH [2, 3]. TeM He MeHee <PYHKUHOHH-pOBaHHe CBePTbIBaHHH KaK e~HHoR CHCTeMbI H pOJIb OT~eJIbHbIX pe-aK~HR B ero peryJIH~HH npe~CTaBJIHIOT c0601t 3ara.nKY, KOTOpaHJIHWb He~aBHO Ha'laJIa nOCTeneHHO paCKPbIBaTbCH 6JIarO~apH CO-BMeCTHbIM YCHJIHHM Bpa'lelt, 6HOXHMHKOB, 6HO<pH3HKOB H MaTeMa-THKOB. 3TH pe3YJIbTaTbI y)Ke ceR'Iac npHBOJ1,HT K nOHBJIeHHIO HOBbIX~eR H MeTO~OB B ~HarHOCTHKe H TepanHH pa3JIH'IHbIX naTOJIOrHItreMOCTaJa. l(eJIblO ~aHHoro 0630pa HBmleTCH paCCMOTPeHHe cyme-CTBYIOIUHX ~OCTH}KeHHit H np06JIeM B 3TOit 06JIacTH.

JIHMepOB, KOTOpbIe MOryr JIarepaJIbHO arperHpOBaTb, 4>OPMHPYH HH-TH 4>H6pHHoBOrO BOJIOKHa. BOJlOKHa p83BeTBJISIJOTCH, 06pa3YH Tpex-MepHYJO CeTb 4>H6pHHoBOrO cryCTKa.

KpOMe TOrO, TPOM6HH ytIaCTByeT BO MHO)KeCTBe TaK H83bIBae-MbIX 06paTHbiX CBH3e~ - peryJIHTOpHbIX peaKUH~, B KOTOpbIX OH

BJIHHeT Ha CBOe C06CTBeHHOe npOH3BOJ!CTBO. OCHOBHbIMH TaKHMHpeaK~HHMH HBJUlJOTCH peaKUHH aKTHBa~HH TpOM6HHOM 4>aKTOpOBV, VIII, XI H nporeHHa C. <I>aKTOpbI V H VIII npeJ!CTaBJIHJOT c060~npeJ!wecTBeHHliKH Ko4>aKTOpoB, Ii nOCJIe aKTliBBUHIi TpoM6liHOMcnoc06HbI Ha HeCKOJIbKO nopjIJIKOB YBeJlH'IliBaTb CKOpOCTb pa60TbI4>aKTOpOB Xa Ii IXa COOTBeTCTBeHHO [5, 7, 8]. 31"0 J!ocrnraeTCH ny-TeM C60PKii 4>epMeHTarnBHbIX KOMnJIeKCOB npOTpOM6liH83bI (4>aK-TOpbI Xa-Va) Ii BHYTpeHHe~ reHa3bI (4>aKTOpbI IXa-VIIIa) HaMeM6paHax aKrnBlipOBaHHbIx TpoM60~TOB. <I>aKTop XI HBJUleTCHnpeJ!weCTBeHHliKoM cepliHoBo~ nporeliHa3bI, KOTOpbI~ noCJIe aK-TliBa~liH TPOM6liHOM (HJlIi 4>aKTOpOM Xlia li3 KOHTaKTHOrO llYTliaKTHBa~1i1i CBepTbiBaHliH) cnoc06eH aKTHBlipOBaTb 4>aKTOp IX [9,

10].TpH paCCMOTPeHHbIe neTJIH 06paTHO~ CBjl3H OTHOCjlTCjI K KJIaC-

cy nOJlO)KHTeJIbHbIX: B HHX TPOM6HH YCKOpjleT CBOe CO6CTBeHHOenpOH3BOJJ,CTBO. HanpOTHB, nyrb npOTeHHa C jlBJUleTCjI Ba)KHe~llIe~OTPHuaTeJlbHO~ o6paTHo~ CBjl3blO, B KOTOpO~ TPOM6HH HHrn6HPYeTCBOIO aKTHBauHIO. npOTeHH C npeJJ,CTaBJUIeT co6o~ npeJJ.llIeCTBeH-HHK CepHHoBoit npOTeHHaJbI. no CBoeit MOJIeKYJUIpHoit cTPYKTYPeOH O'ieHb nOXO)K Ha llJaKTOpbI IX, X, VII H npoTPoM6HH. npH aK-THBaUHH TPoM6HHOM noJlyqHBIlI~CjI npOTeHHaJa npoH3BOJJ,HT He-CKOJlbKO npOTeOJIHTH'ieCKHX paCllIenJIeHHit B llJax:ropax CBepTbIBa-HHj{ Va H VIIIa, 3aCTaBJUUI HX nOJIHOCTbIO TepjlTb CBOH KollJaKTOp-HbIe cBoitCTBa [11]. Ba)KHbIM peryJUITOpOM nYTH npOTeHHa C jlBJUI-eTCH TPOM6oMOJJ,YJIHH, MeM6paHHbIit 6eJIOK, SKcnpeccHpyeMbIit SH-JJ,OTeJlHeM. OH CBjl3bIBaeT TPOM6HH, YBeJIH'iHB~ Ha HeCKOJIbKO no-PJJJJ.KOB CKOpOCTb aKTHBauHH npOTeHHa C TPOM6HHOM Ha nOBepx-HOCTH SHJJ,OTeJIHH [12].

J].JIJI peryJUIUHH npouecca cBepTbIBaHHjI B KpOBH npHcyrcTByJOTHHfH6HTOpbI cepHHoBblX npOTeHHaJ. OCHOBHbIMH HHfH6HTopaMHcBepTbIBaHHH HBJUlIOTCH aHTHTpoM6HH III, HHfH6HPYlOLUHit nO'irnBce llJaKTOpbI CBepTbIBaHHjI KpOMe llJaKTopa VIla, H HHrn6HTop nyrHT<I> (tissue factor pathway inhibitor HJlH TFPI), HHfH6HPYlOLUHitBHeWHlO1O TeHaJY [13-15].

nOMHMO nyrH T<I> CBepTblBaHHe MO)KeT aKTHBHpOBaTbCH no TaKHaJblBaeMOMY KOHTaKTHOMY nyrH. OCHOBHoit 6eJIOK STOfO nyrH,llJaKTop XII, aKTHBHpYeTCH npH KOHTaKTe nJla3MbI C npaKTH'ieCKHJl1O6o~ 'iy)KepoJJ,Ho~ nOBepXHOCTbIO, a 3aTeM aKTHBHpYeT llJaKTop XI[16]. nOCKOJIbKY C'iHTaeTCH, 'iTO OH He HrpaeT pOJIH B HOpMaJlbHOMCBePTbIBaHHH, OH He nOKa3aH Ha pHC. 1. TeM He MeHee eCTb JJ,aHHbIe,'ITO OH MO)KeT HrpaTb Ba)KHbIe pOJIH B JJ,pyrHX cHcTeMax opfaHH3Ma,a TaK)Ke B naTOJIOfH'IeCKOM CBepTbIBaHHH [Ib].

BHOXHMHJI CBepTblBaHHJI KpOBH

KJTeTKH npaKTM'leCKH BCeX TKaHe~ OpraHM3Ma, 3a MCKJIIO'leHM-HM 3!{JlOTeJlMH M KJIeTOK KpOBM, 3KCnpeCCMpylOT TPaHCMeM6paHHbli%6eJIOK - TKaHeBbI~ q,aKTOp (T<I». TaKMM 06PaJOM, JIIO60e nOBpe-

)K.!1eHMe 3!{JlOTeJIMH npMBO~MT K TOMY, 'lTO nJIa3Ma KpOBM BCTYnaeTB KOHTaKT C KJIeTKaMM, HeCY\UMMM T<I>. B nJIaJMe nOCTOHHHO npM-

CYTCTByeT q,aKTOp VIla (OCHOBHble 6eJ1KH CMCTeMbI CBePTbIBaHMHHaJblBalOTCH q,aKTOpaMM CBePTblBaHMH Ii, npOHYMepOBaHbI B noPM-Ke OTKpblTHH; CMMBOJI "a" 0603Ha'laeT aKTMBMpOBaHHYIO q,OPMY 6eJI-

Ka), cepMHOBaJI npOTeHHaJa, KOTOpaJI caMa no ce6e no'lTM He 06-

JIa,naeT q,epMeHTaTHBHO~ aKTMBHOCTbIO. Kor~a q,aKTop VIla CBH3b1-BaeTCH C T<I>, nOJIyqMB\UM~CH KOMnJIeKC, Ha3b1BaeMbIi% BHeIUHe~ Te-

HaJO~ [4], npM06peTaeT cnoC06HOCTb aKTHBMpOBaTb q,aKTOpbl IX MX. KaK M nO'lTM Bce q,ax:rOpbl CBepTblBaHMH, OHM CMHTe3MpylOTCH H

~MPKYJIMpylOT B KpOBOTOKe B HeaKTMBHoi% q,opMe. I1x aKTHBa~MH

npe~CTaBmreT c060i% pa3pe3aHMe MOJIeKYJIbI 6eJ1Ka B O~HOM MJIH He-CKOJIbKHX MecTax, KOTopoe OTKpblBaeT era aKTHBHbI~ Cai%T M M3Me-

HHeT KOHq,OpMal!MIO TaK, '!TO 6eJIOK CTaHOBMTCH aKTMBHblM q,ep-

MeHTOM, cnoc06HbIM caMOCTOHTeJIbHO npoM3BO~MTb paJpe3b1 B ~PY-rMX 6eJIKax. OnMcaHHaH CMCTeMa pea~Mi%, OTBe'lalO\UHX 3a 3anycK

cBepTblBaHMH, HaJblBaeTCH BHelUHHM nyreM CBepTblBaHMH, MJIM ny-TeMT<I> [4).

<l>aKTop Xa cnoc06eH KaTaJIH3MpOBaTb npeBpa\UeHMe npOTPOM-6MHa B aKTHBHyIO cepMHOByIO npOTeMHaJY TPoM6MH, KOTOpbl~ HB-JIHeTCH rJIaBHblM q,epMeHTOM CBepTbIBaHMH [5]. I1MeHHo TPoM6MHocy\UeCTBJIHeT npeBpa\UeHMe 6eJIKa q,M6pMHoreHa B q,M6pMH [6].

MoJIeKYJIbI q,M6pMHa ~aJIee cnoc06HbI 06pa30BblBaTb ~enO'lKH no-

88 -

MexaHH3MbI peryJlHUHH CBepTbIBaHHH KpOBI

PHC. I. OCHOBHble peaKUHH ruJa3MeHHOH CHCTeMbI CBepTbIBaHI1H KpOBH. PeaKUl111 <l>epMeHTaTHBHoro KaTaJII13a 11npeBpalUeHHH nOlI fro lIeHCTBHeM nOKa3aHbI cepbIMH H 'iepHbIMH CTpeJIKaMI1 COOTBeTCTBeHHO, 06paTI1Mble peaK-

UI1H <l>opMHpoBaHHH KOMruJeKCOB - lIBYCTOPOHHHMH CTpeJIKaMH, HHrn611pOBaHHe - KOpOTKHMH nYCTbIMI1 cTpeJI-

KaMH.TF - TKaHeBb'!! I\1aKTop. Fg - I\1H6pHHoreH. Fn - I\1H6pHH.

IIPH nepBOM 3HaKOMCTBe CHCTeMa CBepTbIBaHHSI HeH36e)KHo

nOp~aeT HCCJIellOBaTeJISI CBOeM CJIOJKHOCTblO H 3anYTaHHOCTblO. IIo

Mepe yrJIy6JIeHHOrO H3yqeHHH 3TO BneqaTJIeHHe 06~qHO TOJIbKOYCHJIHBaeTCH. IIOqeMY 3Ta CHCTeMa YCTPOeHa TaK CJIOJKHO? qHCJIO

peaKIIHM, Heo6xOllHMOCTb KOTOp~X OqeBHlIHa, B HeM MO)KHO COCqH-TaTb no naJIbuaM: HX pOBHO lIBe. OllHa peaKlIHSI - 3TO CBH3~BaHHecPaKTopa VIla C 06H~HBIlIHMCH T<I>, KOTOpaSl pacnO3HaeT MeCTO iICOCYlIHCTOM CTeHKe, rlle npOH30IlIJlO nOBpe)((lJeHHe. BTOPaSl - 3TO

aKTHBaUllil H nOJIHMepH3aUHSI cPH6pHHa, KOTOpaSl BblnOJIHHeT He-

nOCpellCTBeHHYIO 3alJaqy CHCTeMbI no CO3llaHHIO crycTKa. Teopem-qeCKH, cPaKTOp VIla Mor 6~ aKTHBHpoBaTb cPH6pHHoreH HanpSlMYIO,H TaKaSI CHCTeMa BnOJIHe MOrJIa 6~ CO3llaBaTb crycTOK Ha MeCTe no-

Bpe)((lJeHHH 6e3 yqacTHSI lIeCHTKOB npOqHX 6eJIKOB. TaK 3aqeM JKe

OHH HyJKHbI?

3TOT Bonpoc He SlBJIHeTCH npa3l!H~M, OH OllHHaKOBO aKTYaJIeH H

JJ)!5I 6HOXHMHH, H lI)IH cPapMaKOJIOrHH, H lI)ISI TepanHH. HapYIlleHHH

CBePTbIBaHHH KpOBH SlBJIHIOTCSI OllHOM H3 HaH6oJIee pacnpOCTPaHeH-H~X npwqHH CMePTHocm B MHpe, H OllHa H3 HaH6oJIee aKTYaJIbHbIX3a.!laq BceM MellHUHH~ - HayqHTbcSI cTa6HJIbHO peryJIHpOBaTb H

KoppeKmpo,aTb 3TY CHCTeMY. B HaCTOSlmHM MOMeHT lI~e JIyqlllHeH3 lIOCTYfiHblX JIeKapCTBeHHbIX cpellCTB He cnoco6HbI npellOTBpa-

THTb KpOBOTeqeHHe 6e3 CO3llaHHH onaCHOCTH pa3BHTHH TPoM6o3a

HJIH nOllaBHTbnaTOJIOrHqeCKOe CBePTbIBaHlliI 6e3 nO60qHOrO KpO-

BOTeqeHlliI. Be3 nOHHMaHlliI MexaHH3MOB peryJIHUHH 3TOM CHCTeMbI

cTa6HJIbHO 3cPcPeKTHBHaSI H ruJaHOMepHaSI KoppeKlIlliI ee HapYllIe-HHM HeBO3MOJKHa.

CI1CTeMa KpOBO06palUeHlliI 4eJlOBeKa I1MeeT BbICOKYIO 3<p<peK-

TI1BHOCTb 6J1arO!{apH BbICOKI1M CKOpOCTHM, BbICOKl1M !{aBJIeHI1HM,

HaJlI14111O MHOr0411CJleHHbiX MeJlb4aHIIII1X KanIfJlJIHpOB, 3aKJI1O4e-HI1IO reMorJl0611Ha B 3pI1TpOIjI1TbI. Ho 3a BCe 3TO npI1XO!{I1TCH llJIa-

TI1Tb: BbICOKOe !{aBJIeHHe Be!{eT K 6bICTpOH KpOBOnOTepe npl1 nOBpe-

~eHI1H, CJlO)KHbIH COCTaB KpOBI1 3aTpY!{HHeT BOCCTaHOBJIeHHe ee

06'beMa, 4pe3BbI4aHHO pa3BeTBJleHHaH COCY!{HCTaH CHCTeMa 11 HaJlH-4He KJleTOK 3aTpy!{HHIOT pa60ry cep!{lja !{~e npl1 He60JlblIlOM

YMeHblIleHHH 06'beMa. 3T11 06CTOHTeJlbCTBa Tpe6y1OT OT CI1CTeMbICBePTbIBaHHH BblCOKOH 3<p<peKTI1BHOCTI1. C !{pyrOH CTOpOHbl, OTKa3OT OTKpblTOH CI1CTeMbI KpOBO06palIleHlliI !{eJlaeT TPOM603bI CMep-

TeJlbHO OnaCHbIMl111 npe!{'bHBJlHeT OC06bIe Tpe60BaHHH K aHTHTpOM-

60TH4eCKOH nO!{CHCTeMe. ll03TOMY CI1CTeMa CBepTbIBaHlliI B ee HbI-HelIlHeM Bl1.l1e npe!{CTaBJUIeT c060ij CJlO)((HbIH MeXaHH3M, KOTOpbIH

npl13Bafi He npOCTO !{eJlaTb cryCTOK Be3!{e, r!{e nOHBI1TCH T<I>, HO pe-

ryJlHpOBaTb pa3Mep 11 Ka4eCTBO 3Toro cryCTKa TaK, 4T06bI npe!{OT-

BpaTI1Tb KpOBonOTeplO H 1136e)((aTb onaCHOCTI1 TpoM603a.

B !{aHHOM 0630pe MbI COCpe!{OT04I1MCH Ha I1CCJle!{OBaHlliIX pOJlI1

neTeJlb nOJlO)((I1TeJlbHOH 11 OTpl1ljaTeJlbHOH 06paTHOH CBH3H B pery-

JUlIjHI1 npOCTpaHCTBeHHOH !{HHaMHKH TpOM6006pa30BaHlliI. DOJlee

!{eTaJlbHaH I1H<popMaIjHH 0 !{pyrl1x npe!{nOJlaraeMbIX <PYHKIIlliIX pa3-JII14HbiX 4aCTeH CI1CTeMbI CBepTbIBaHHH MO)((eT 6bITb HaH.neHa B 06-

30pax [3, 5, 9, 13, 16, 18, 21, 22].HaH60Jlee pacnpOCTpaHeHHbIMH HaCJle!{CTBeHHbIMH 3a60JleBa-

HlliIMI1 CBepTbIBaHI1H HBJlHIOTCH reMo<pI1JIHH - 60Jle3HI1 KpOBOTO-

4HBOCTH, CBH3aHHbie C !{e<pHIjHTaMH I1JIH !{e<peKTaMH <paKTOpOB

CBepTbIBaHI1H VIII, IX, I1JII1 XI (reMo<pI1JIHH A, B 11 C COOTBeTCT-

BeHHo) [1, 7]. AJIH HCCJle!{OBaHI1H pOJlH paJJIH4HbIX peaKIIHH B npo-CTpaHCTBeHHOH !{I1HaMHKe CBepTbIBaHHH KpOBH B HalIleH JIa60paTo-pl1l1 6bIJ1a pa3pa60TaHa MeTO!{HKa HCCJle!{OBaHHH npOCTpaHCTBeHHO-ro CBepTblBaHHH no perHcTpaljl1H cBeTopacceHHlliI OT crycTKa, BbI-

palIleHHoro B HenepeMelIlHBaeMoH llJIa3Me [23]. CBePTbIBaHHe npo-I1CXO!{I1JIO B CneljHaJlbHOH KIOBeTe, O!{Ha H3 CTeHOK KOTOpOH npe!{-CTaRlJMa CO60H aKTHBaTop. C nOMO~1O 3TOIt YCTaHOBKI1 HaMH 6bI-

JIa BbInOJlHeHa cepllil HCCJle!{OBaHHH, nO3BOJlHBIIIHX BbIHBI1Tb Mexa-

HI13MbI HapYlIleHlliI TpoM6oo6paJoBaHlliI npH reMo<pl1JIlliIX [23-

25]. TI1nH4Hbie <poTorpa<pHH paCTYlUerO CryCTKa B llJIa3Me 60JlbHbIX,

!{e<pHIjHTHbIX no pa3JIH4HbIM <paKTOpaM cBepTbIBaHlliI, npe!{CTaBJIe-HbI Ha pHC. 2. MHl1ljHaljllil CBepTbIBaHlliI B llJIa3Me 60JlbHOrO reMO'"

<pHJlHeH A npol1cxo!{l1JIa HOpMaJlbHO, B TO BpeMH KaK pacnpOCTpa-HeHl1e npOljeCca BrJly6b llJIa3MbI 6bIJlO Cl1JIbHO HapYlIleHO, CKOPOCTb

npOCTpaHCTBeHHoro pOCTa crycTKa 6bIJ1a B 3-4 pa3a MeHblIle, 4eMB HopMe. llpl1 !{e<pI1IjHTe <paKTopa XI pa3JI114lli1 6bIJ1H MeHblIle H

npOHBJlMHCb Ha 6oJlee nO3llHI1X 3Tanax, 'lTO corJlaCYeTCH C MeHeeTH)((eJlbIMH KpoBoTe4eHHHMI1, Ha6J1IO!{aeMbrMH npl1 reMo<pI1JII1H C.

MeX3HH3Mbl peryJlJl~H CBepTblB3HHIl KpOBH

nepBbIe npHH~HnHaJlbHbIe OTBeTbI Ha 3ara,uKY CHCTeMbI CBep-TbIBaHHSI nOSlBHJIHCb 6JIaro~apSl aKTHBHbIM HCCJIellOBaHlUIM CBepTbI-

BaHlUI y ~pyrnx BHllOB )l(HBbIX CYlUeCTB, B qaCTHOCTH y 6eCn03BO-

HOqHblX [17-20]. CpaBHeHHe YCTPOHcTBa CHCTeM CBepTbIBaHHSI Y

pa3HblX BHllOB }KHBbIX opraHH3MOB nOKa3aJ10, 'iTa HX CJIO)KHOCTb co-

OTBeTCTBYeT CJIO)l(HOCTH COCYllHCTOH CHCTeMbl. AC~HllHH, npHMH-THBHbIe 6ecn03BOHOQHbIe XopllOBbIe, 06xOJJJITCSI Bo06we 6e3 nJIa3-

MeHHoH CHCTeMbI CBePTbIBaHHSI. MeqeXBOCTbl, "}KHBble HCKonae-

MbIe" H po~cTBeHHHKH llpeBHHX X03S1eB MopeH paKOCKopnHOHOB,

HCnOJIb3y1OT He60JIbWOH KaCKa,u pea~HH 6e3 pa3BeTBJIeHH~ H 06-paTHblX cBSl3e~ (HMeIOWH~, no-BHllHMOMY, CKopee HMMYHHyIO

~YH~HIO, He)l(eJIH reMOCTaTHqeCKYIO). DJIarOllapH npHMHTHBHO~

OTKpbITO~ CHCTeMe KpoBo06paweHHSI C HeCKOJIbKHMH KpynHbIMH

COCYllaMH (HJIH npOCTO nOJIOCTblO, rlle nJIaBalOT BHYTPeHHHe opra-HbI) H MeW]eHHbIM nOTOKOM 3TH cYlUeCTBa He CJIHIlIKOM 60SlTCSI HH

6bICTPO~ nOTepH reMOJIHM~bI npH paHeHHH, HH TPoM603a.

89

HeHHe TaKHX nOJI.XOJI.OB 6YJI.eT JIHJI.HpyIOIltHM HanpaBJIeHHeM B 611H-IKal%IltHe rOJI.bI.

Pa6oTa 6bJJ1a 'laCTH'lHO nOJI.JI.eplKaHa rpaHTaMH P<I><I>11 06~04-48426 H 07-04-00146, a TaKlKe rpaHTOM "Pa3pa6oTKa npHHUHnHaJIb-HO HOBoro nJIa3MO3aMelltaJOIltero pacTBopa, o611a.!{aJOlltero <!>YHKUH-el% KoppeKUHH reMOCTa3a B YCJ10BHHX MaCCHBHblX nepellHBaHHI%" BpaMKax nporpaMMbI <!>YH.!(aMeHTaJIbHbIX HcclIeJtoBaHHI% llpe3HJtJly-Ma PAR "<I>YH.IIaMeHTaJIbHble HaYKH - MeJtHUHHe".

13. Bajaj M. S., Birktoft J. J., Steer S. A., Bajaj S. P. Structure andbiology of tissue factor pathway inhibitor. Thromb. Haemost.2001; 86: 959-972.

14. Ellis JI:, Scully M., MacGregor I., Kakkar JI: Inhibition of hu-man factor Xa by various plasma protease inhibitors. Biochim.Biochim. Biophys. Acta 1982; 701 (1): 24-31.

15. Ellis V., Scully M. F., Kakkar JI: JI: Inhibition of prothrombi-nase complex by plasma proteinase inhibitors. Biochemistry1984; 23 (24): 5882-5887.

16. Colman R. W:, Schmaier A. H. Contact system: a vascular biol-ogy modulator with anticoagulant, profibrinolytic, antiadhe-sive, and proinflammatory attributes. Blood 1997; 90: 3819-3843.

17. Bishopric N. H. Evolution of the heart from bacteria to man.Ann. N. Y. Acad. Sci. 2005; 1047: 13-29. .

18. Hogan K. A., Weiler H" Lord S. T. Mouse models in coagula-tion. Thromb.. Haemost. 2002; 87 (4): 563-574.

19. Iwanaga S., Kawabata S. Evolution and phylogeny of defensemo1ectlles associated with innate immunity in horseshoe crab.Front. Biosci. 1998; 3: D973-D984.

20. Davidson C. J., Tuddenham E. G., McVey J. H. 450 millionyears of hemostasis. J. Thromb. Haemost. 2003; 1 (7): 1487-1494.

21. Beltrami E., Jesty J. The role of membrane patch size and flowin regulating a proteolytic feedback threshold on a membrane:possible application in blood coagulation. Mathemat. Biosci.2001; 172 (1): 1-13.

22. Dale G. L. Coated-platelets: an emerging component of theprocoagulant response. J. Thromb. Haemost. 2005; 3 (10):2185-2192.

23. Ovanesov M. JI:, Krasotkina J. J-:, m'yanova L. I. et al. Hemo-philia A and B are associated with abnormal spatial dynamicsof clot growth. Biochim. Biophys. Acta 2002; 1572 (1): 45-57.

24. Ovanesov M. JI:, Ananyeva N. M, Panteleev M. A. et al. Initia-tion and propagation of coagulation from tissue factor bearingcell monolayers to plasma: initiator cells do not regulate spatialgrowth rate. J. Thromb. Haemost. 2005; 3 (2): 321-331.

25. Panteleev M. A., Ovanesov M. JI:, Kireev D. A. et al. Spatialpropagation and localization of blood coagulation are regulatedby intrinsic and protein C pathways, respectively. Biophys. J.2006; 90 (5): 1489-1500.

JIMTEPATYPA

1. Colman R. W Hemostasis and thrombosis basic principles andclinical practice. 3-rd ed. Philadelphia: Lippincott, .1993.

2. Schenone M., Furie B. C., Furie B. The blood coagulation cas-cade. Curro Opin. Hematol. 2004; 11 (4): 272-277.

3. Hoffman M., Monroe Do. M. Coagulation 2006: a modern viewof hemostasis. Hematol. Oncol. Clin. N. Am. 2007; 21 (.1): 1-11.

4. Monroe D. M., Key N. S. The tissue factor-factor Vila com-plex: procoagulant activity, regulation, and multitasking. J.Thromb. Haemost. 2007; 5 (6): 1097-.1105.

5. Crawley J. T., Zanardelli S., Chion C. K., Lane D. A. The cen-tral role of thrombin in hemostasis. J. Thromb. Haemost.2007; 5 (suppl. .1): 95~101.

6. Blomback B. Fibrinogen and fibrin - proteins with complexroles in hemostasis and thrombosis. Thromb. Res. 1996; 83(1): 1-75.

7. Fay P. J. Activation of factor VIII and mechanisms of cofactoraction. Blood Rev. 2004; 18(1): 1-15.

8. Monkovic D. D., Tracy P. B. Activation of human factor V byfactor Xa and thrombin. Biochemistry 1990; 29 (5): 1118-1128.

9. Gailani D., Broze G. J. Jr. Factor XI activation in a revisedmodel of blood coagulation. Science 1991; 253 (5022): 909-912.

10. Gailani D., Ho D., Sun M. F. et al. Model for a factor IX acti-vation complex on blood platelets: dimeric conformation offactor XIa is essential. Blood 2001; 97 (10): 3117-3122.

11. Walker F. J., Fay P. J. Regulation of blood coagulation by theprotein C system. FASEB J. 1992; 6 (8): 2561-2567.

12. Esmon N. L., DeBault L. E., Esmon C. T. Proteolytic forma-tion and properties of gamma-carboxyglutamic acid-domain-less protein C. J. Biol. Chern. 1983; 258: 5548-5553. nocrynHn8 08.02.08

/C) KOJIJIEKTHB ABTOPOB, 2008

Y~K 615.277.3.032:611-018.51

A. F. TUXOHOeaJ, 10. F. AAeICCaHapOeUtt, T. A. ByiiMo!, E. H. CuHaypUa3eJ, <P. H. AmaYJUlaxaHOeJ, 2, J

3PHTPO~HTbI - llEPEHOC1JHKH AHTP~HKJIHHOBblX AHTHEHOTHKOB

IJIa6RpaTOpHH <pH3HtfeCKott 6HOXHMHH CHCTeMhI KpOBH ry reMaTOJlOrH'leCKOrO HayqHoro ueHTpa PAMH, MOCKBa; 2ry l(eHTpTeOpeTHtfeCKHX npO6JIeM cPH3HKO-XHMHtfeCKott cPapMaKOJlOrHH PAMH; 3cPH3HtfecKHtt cPaKYJlbTeT, Mry HM M. B. JIOMoHocOBa

K JI 10 q e B hI e C JI 0 B a: o63op, 3pumpo~umbl-HOCUmeJIU, aHmpa~U/CJ1UH06b1e aHmu6uomUKU, aoKcopy6u~UH,aaYHopy6u~UH, MumOKcaHmpOH, MemOabi 6/CJ1/oljeHUR npenapam06 6 3pumpo~umbi

Key W 0 r d s: review, erythrocytes carriers, anthracycline antibiotics, doxorubicin, daunorubicin, mitoxantron,methods of drug inclusion into erythrocytes

AmpaUHKJIHHOBbie aHTH6HOTHKH - HaH6oJIee lIIHpOKO HCnOJIb-3yeMbie B KJIHHHKe npOTHBOOnYXOJIeBbie npenapaTbi. OHH 3<l1<l1eK-THBHbI npH JIe'leHHH MHeJIOnpOJIH<lIepaTHBHbIX 3a6oJIeBaHH~, a TaK-)Ke pSl,Qa J{PYrnx onYXOJIe~. BnepBble aHTPaUHKJIHHbI J{aYHOpy6HUHH(py60MHUHH) H J{oKcopy6HUHH 6blJ1H Bbr.neJIeHbI H3 Streptomyces spp.B Ha'laJIe 1960 rr. MHTOKCaHTpOH - cHHTeTH'IeCKH~ aHaJlOr 3THXnpenapaTOB. XHMH'IeCKH Bce aHTPaUHKJIHHbI COCTORT H3 arJIHKOHO-Boro KOJIbua, CBH3aHHoro C aMHHocaxapoM (pHC. 1).

BBeJteHHble BHyrpHBeHHo, aHTpaUHKJIHHOBbie aHTH6HOTHKH6bICTpO BblBOJ1,HTCH H3 KpOBeHOCHoro pYCJIa. KHHeTHKY BblBeJ{eHHHcBo6oJ{HblX J{aYHOpy6HUHHa H J{OKCopy6HUHHa MO)KHO OnHCaTb KaKJ{Byx<lla3HYJO. llocJIe BHYTpHBeHHoro BBeJ{eHHJI 3THX npenapaToB HXKOHueHTpaUHJI B re'leHHe nepBblX 30-60 MHH pe3KO yMeHblIIaeTcHH 'Iepe3 12-24 'I COCTaBJIJleT MeHee 1% OT Ha'laJIbHO~ (nHKoBo~)KoHueHTPaUHH [1]. BbicoKaJI TOKCH'IHOCTb aHTpaUHKJIHHOBbiX aH-TH6HOTHKOB BO MHorOM o6YCJIOBJIeHa Bo3Jte~CTBHeM BbiCOKOR UH-

KOBO~ KOHueHTpaUHH cBo6o~HOrO aHTH6HOTHKa B MOMeHT BBe~e-HHH. I1x nO60'lHble 3<l><l>eKThl BKJlIO'laIOT MHeJIOcynpeccHIO, HeKpO3TKaHett (eCJIH aHTH6HOTHKH BBe~eHhI nOJ{KO)KHo), aJlOneUHIO, no-Bpe~eHHH CJIH3HCTO~ 060JIO'lKH )KeJIY~O'lHO-KHllIe'lHOrO TPaKTa H~O303aBHCHMyJO KYMYJUlTHBHyJO Kap~HOTOKCH'IHOCTh [2, 3]. 3a.na'lYnOMep)KaHHH B OpraHH3Me repaneBTH'IeCKo1t KoHUeHTPauHH aHTH-6HOTHKOB B Te'leHHe 6oJIee l1.lIHTeJlbHOrO BpeMeHH H YMeHbllIeHHHHX TOKCH'lHOCTH MHorHe HCCJIe~OBareJIH nbITaJlHCb pellIHTb nyreMHCnOJIbJOBaHHH pa3JIH'lHbIX nepeHOC'IHKOB.

O~HO~ H3 llIHpOKO pacnpocTPaHeHHblX JIeKapCTBeHHhIX <l>oPM3THX npenapaToB, cYllIeCTByJO~Hx B ~aHHbI1t MOMeHT, HBmIJOTCHJIHnOCOMbi - MHKpOCKOnH'IeCKHe 'IaCTHUbI, MarepHaJlOM Jl)UI KO-

TOpbIX CJIy)KaT rHJ{po<l>o6HhIe nomrpHhIe <l>oc<l>OJIHn~bI, HeCYUIHeBHyrpH paCTBOp JIeKapCTBeHHOro Be~eCTBa [4-6]..nmr ~aYHopy6H-UHHa H ~oKcopy6HUHHa cYllIecTByJOT JIHnOCOMaJlbHhIe <l>oPMbI -DaunoXome (~aYHopy6HUHH) H Doxil (~0Kcopy6HUHH). BpeMH no-

91